CLOMIPRAMINE HYDROCHLORIDE for Obsessive-Compulsive Disorder
Not reviewed
CLOMIPRAMINE HYDROCHLORIDE
Learn what this care may do. See what research says. Then check where to get care. A place may not be taking new patients.
Explore for Obsessive-Compulsive DisorderIdentity
Clomipramine hydrochloride (Anafranil) is a prescription capsule medication whose retained U.S. labeling is indicated for obsessions and compulsions in patients with obsessive-compulsive disorder (OCD).
DailyMed clomipramine (Anafranil) label · checked Oct 16, 2026
Relationship: supports
Statement scope
- Formulation or format
capsule
- Indication
treatment of obsessions and compulsions in Obsessive-Compulsive Disorder (OCD)
- Labeler
SpecGx LLC
- Population
patients with Obsessive-Compulsive Disorder whose obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning (DSM-III-R); labeled effectiveness data include adults and children and adolescents 10 to 17 years of age
- Product
ANAFRANIL (clomipramine hydrochloride) capsule
- Section code
34067-9
Source collection coverage: country:US
Pointer: /sections/0
Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).
Open sourceWhy-linked
EveryOption links this treatment to OCD because the retained DailyMed Anafranil label Indications and Usage section states that Anafranil (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with OCD. That exact-pair claim was independently appraised as supported for the retained source record.
DailyMed clomipramine (Anafranil) label · checked Oct 16, 2026
Relationship: supports
Statement scope
- Formulation or format
capsule
- Indication
treatment of obsessions and compulsions in Obsessive-Compulsive Disorder (OCD)
- Labeler
SpecGx LLC
- Population
patients with Obsessive-Compulsive Disorder whose obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning (DSM-III-R); labeled effectiveness data include adults and children and adolescents 10 to 17 years of age
- Product
ANAFRANIL (clomipramine hydrochloride) capsule
- Section code
34067-9
Source collection coverage: country:US
Pointer: /sections/0
Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).
Open sourceIndication-label
The retained Anafranil Indications and Usage labeling describes use for obsessions and compulsions in patients with OCD, including labeled effectiveness context for adults and for children and adolescents 10 to 17 years of age as stated on that label.
DailyMed clomipramine (Anafranil) label · checked Oct 16, 2026
Relationship: supports
Statement scope
- Formulation or format
capsule
- Indication
treatment of obsessions and compulsions in Obsessive-Compulsive Disorder (OCD)
- Labeler
SpecGx LLC
- Population
patients with Obsessive-Compulsive Disorder whose obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning (DSM-III-R); labeled effectiveness data include adults and children and adolescents 10 to 17 years of age
- Product
ANAFRANIL (clomipramine hydrochloride) capsule
- Section code
34067-9
Source collection coverage: country:US
Pointer: /sections/0
Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).
Open sourceScope
Product and population scope follows the retained capsule label context for patients with OCD whose obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with functioning, as labeled. This page does not establish dosing instructions, comparative effectiveness, or FDA approval status beyond what the retained Indications and Usage text supports. Access and availability are not shown here.
DailyMed clomipramine (Anafranil) label · checked Oct 16, 2026
Relationship: supports
Statement scope
- Formulation or format
capsule
- Indication
treatment of obsessions and compulsions in Obsessive-Compulsive Disorder (OCD)
- Labeler
SpecGx LLC
- Population
patients with Obsessive-Compulsive Disorder whose obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning (DSM-III-R); labeled effectiveness data include adults and children and adolescents 10 to 17 years of age
- Product
ANAFRANIL (clomipramine hydrochloride) capsule
- Section code
34067-9
Source collection coverage: country:US
Pointer: /sections/0
Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).
Open sourceProvenance
Source: DailyMed (NLM) SPL label for Anafranil (clomipramine hydrochloride), SET 4074b555-7635-41a9-809d-fae3b3610059 version 22, Indications and Usage section. Attribution follows EveryOption’s adopted DailyMed editorial-use profile; NLM hosting is not a license grant.
DailyMed clomipramine (Anafranil) label · checked Oct 16, 2026
Relationship: supports
Statement scope
- Formulation or format
capsule
- Indication
treatment of obsessions and compulsions in Obsessive-Compulsive Disorder (OCD)
- Labeler
SpecGx LLC
- Population
patients with Obsessive-Compulsive Disorder whose obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning (DSM-III-R); labeled effectiveness data include adults and children and adolescents 10 to 17 years of age
- Product
ANAFRANIL (clomipramine hydrochloride) capsule
- Section code
34067-9
Source collection coverage: country:US
Pointer: /sections/0
Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).
Open sourcePublished Sep 19, 2026Revision 1 · EveryOptionEnglish (United States)
Published Need uses
Select an exact Need to inspect its scoped research. These are the uses currently published on EveryOption; they do not establish every use of CLOMIPRAMINE HYDROCHLORIDE or a personal recommendation.
CLOMIPRAMINE HYDROCHLORIDE for Obsessive-Compulsive Disorder
The research answer belongs to this exact Need and its published scope. It does not establish benefit for other uses of CLOMIPRAMINE HYDROCHLORIDE.
Not reviewed. No current published assessment exists for this exact Treatment and Need. This does not establish benefit or no benefit.
DailyMed clomipramine (Anafranil) label · checked Oct 16, 2026
Relationship: labeled indication
Statement scope
- Formulation or format
capsule
- Indication
treatment of obsessions and compulsions in Obsessive-Compulsive Disorder (OCD)
- Labeler
SpecGx LLC
- Population
patients with Obsessive-Compulsive Disorder whose obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning (DSM-III-R); labeled effectiveness data include adults and children and adolescents 10 to 17 years of age
- Product
ANAFRANIL (clomipramine hydrochloride) capsule
- Section code
34067-9
Source collection coverage: country:US
Pointer: /sections/0
Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).
Open sourceNext: check access
Research and local availability are different facts. Add a place to see known, source-backed access options for CLOMIPRAMINE HYDROCHLORIDE.
Find accessSee something wrong? Tell us. Your note is private. We check sources before we change this page.